References
- Reich, NC, Levine, AJ, et al. Growth regulation of a cellular tumor antigen, p53 in nontransformed cells. Nature 1984; 308: 199–201
- Lane DP. p53, guardian of the genome. Nature 1992; 358: 15–16
- Chen, PL, Chen, YM, et al. Genetic mechanisms of tumour suppression by the human p53 gene. Science 1990; 250: 1576–1580
- Hollstein, M, Sidransky, D, et al. p53 mutations in human cancers. Science 1991; 253: 49–53
- Harris CC, Hollstein M. Clinical implications of the p53 tumour suppressor gene. N Engl J Med 1993
- Levine, AJ, Momand, J, et al. The p53 tumour suppressor gene. Nature 1991; 531: 453–456
- Cattoretti, G, Rilke, F, et al. p53 expression in breast cancer. Int J Cancer 1988; 41: 178–183
- Crawform, LV, Pim, DC, et al. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer 1982; 30: 403–408
- Thor, AD, Moore, DH, et al. Accumulation of p53 tumour suppressor gene protein. J Natl Cancer Inst 1992; 84: 845–855
- Domagala, W, Harezga, B, et al. Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas. Am J Pathol 1993; 142: 669–674
- Hurlimann J. Prognostic value of p53 protein expression in breast carcinomas. Path Res Pract 1993; 198: 996–1003
- Silvestrini, R, Benini, E, et al. p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 1993; 85: 965–970
- Caleffi, M, Teague, MW, et al. p53 gene mutations and steroid receptor status in breast cancer clinicopathological correlations and prognostic assessment. Cancer 1994; 73: 2147–2156
- Barnes, DM, Dublin, EA, et al. Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis?. Human Pathol 1993; 24: 469–476
- World Health Organization. Histological typing of breast tumourssecond edition. 1968, 1981
- Bloom HJC, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer 1957; 11: 359–377
- Elston CW. Grading of invasive carcinoma of the breast. Diagnostic histopathology of the breast, D Page, T Anderson. Churchill Livingstone, Edinburgh 1987; 300–311, In
- Remmele W, Stegner HE. Immunohistochemischer Nachweis von Östrogenrezeptoren (ERICA) in Mammarkarzinomgewebe: Vorschlag zur einheitlichen Formulierung des Untersuchungsbefundes. Dtsch Ärztebl 1986; 83: 3362–3364
- Hanzal, E, Gitsch, G, et al. Immunohistochemical detection of mutant p53-suppressor gene product in patients with breast cancer: influence on metastasis-free survival. Anticancer Res 1992; 12: 2325–2330
- Walker, RA, Dearing, SJ, et al. Expression of p53 protein in infiltrating and in-situ breast carcinomas. J Pathol 1991; 165: 203–211
- Friedrichs, K, Gluba, S, et al. Overexpression of p53 and prognosis in breast cancer. Cancer 1993; 72: 3641–3647
- Iwaya, K, Tsuda, H, et al. Nuclear p53 immunoreaction associated with poor prognosis breast cancer. Jpn J Cancer Res 1991; 82: 835–840
- Allred, DC, Clark, GM, et al. Association of p53 protein expression with tumour cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 1993; 85: 200–206
- Ostrowski, JL, Sawan, A, et al. p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study. J Pathol 1991; 164: 75–81